Five years ago this month, in November 2020, medical history was made at Richmond Pharmacology when a patient received the first CRISPR therapy delivered systemically through the bloodstream, using ...

CRISPR Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 82.

Bispecific antibodies bring multiple tumor-cell-killing mechanisms into play simultaneously. When a T cell is activated and ...

When what was previously scarce suddenly becomes abundant, look for the new scarcity because that is what creates leverage.

CRISPR Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 71 to 82.

A year of new treatments, new technologies, new ways to stay safe during disasters and new insights on the mysteries of the ...

From custom gene editing to a discovery that could help stop pancreatic cancer before it starts, these advances offer a ...

All the way back in 49 BCE, emperor of the known world Julius Caesar sported history’s first known combover — which tells you ...

Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...

Dr Sydney Calkin, from the Department of Geography in Queen Mary University of London’s School of Society and Environment, ...

The problem, Zaaijer explained, is that algorithms used in precision medicine models overwhelming are built on DNA with ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...